| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0095 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |